Monocarboxylate transporter 2 (MCT2) as putative biomarker in prostate cancer (Q34314276)

1 August 2017

Monocarboxylate transporter 2 (MCT2) as putative biomarker in prostate cancer (English)

1 reference

1 August 2017

0 references

1 reference

Nelma Pértega-Gomes

1

1 reference

1 August 2017

José R Vizcaíno

2

1 reference

1 August 2017

Carlos Gouveia

3

1 reference

1 August 2017

Carmen Jerónimo

4

1 reference

1 August 2017

Rui M Henrique

5

1 reference

1 August 2017

Carlos Lopes

6

1 reference

1 August 2017

Fátima Baltazar

7

1 reference

1 August 2017

28 November 2012

1 reference

1 August 2017

1 reference

1 August 2017

73

1 reference

1 August 2017

7

1 reference

1 August 2017

763-769

1 reference

Targeting cancer metabolism: a therapeutic window opens

1 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22620

Role of monocarboxylate transporters in human cancers: state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22620

Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22620

Delineation of prognostic biomarkers in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22620

In mouse alpha -methylacyl-CoA racemase, the same gene product is simultaneously located in mitochondria and peroxisomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22620

Expression of alpha-Methylacyl-CoA racemase (P504S) in atypical adenomatous hyperplasia of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22620

Using an AMACR (P504S)/34betaE12/p63 cocktail for the detection of small focal prostate carcinoma in needle biopsy specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22620

p63 is a prostate basal cell marker and is required for prostate development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22620

Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22620

p63 protein expression is rare in prostate adenocarcinoma: implications for cancer diagnosis and carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22620

The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22620

P504S: a new molecular marker for the detection of prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22620

Is triple immunostaining with 34betaE12, p63, and racemase in prostate cancer advantageous? A tissue microarray study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22620

Increasing incidence of minimal residual cancer in radical prostatectomy specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22620

Diagnostic criteria of limited adenocarcinoma of the prostate on needle biopsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22620

21 January 2018

Identifiers

DOI

10.1002/PROS.22620

1 reference

1 August 2017

1 reference